iX Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.3%.

Top 14 shareholders own 45.68% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
22.3%	Yip Hang Lee	196,552,801	S$4.7m	0%	no data
7.56%	Phuah Lee	66,748,029	S$1.6m	0%	no data
2.35%	Jaspal Narulla	20,727,047	S$497.4k	22%	no data
1.98%	See Tee Tan	17,470,800	S$419.3k	5.53%	no data
1.89%	C2c Biopharma Holdings Pte. Ltd	16,726,200	S$401.4k	22%	no data
1.74%	Hwee Hoon Chan	15,413,027	S$369.9k	18.1%	no data
1.73%	Wetwaters 8 (S) Pte Ltd	15,273,180	S$366.6k	22%	no data
1.72%	Boon Lock Seah	15,164,869	S$364.0k	0%	no data
1.28%	Beng Sng	11,300,000	S$271.2k	100%	no data
1.26%	Shing Tung Ho	11,135,678	S$267.3k	22%	no data
1.14%	Hardeep Kaur	10,032,426	S$240.8k	0%	no data
0.69%	Janakan Krishnarajah	6,092,279	S$146.2k	1,120%	no data
0.087%	PHEIM Asset Management Sdn Bhd	767,860	S$18.4k	0%	0.03%
0.016%	Centrum Capital Pte. Ltd, Asset Management Arm	139,100	S$3.3k	0%	no data